Related Experiment Video
Updated: May 26, 2025

10:14
Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
3.0K
Extended phenotypic spectrum of benign yellow dot maculopathy
Peter Kiraly1,2, Johannes Birtel1,2,3, Ariel Y Ong1
1Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Eye (London, England)
|February 21, 2025
Summary
Benign yellow dot maculopathy (BYDM) presents as mild macular yellow dots, often with no vision loss or progression. Recognizing this condition can prevent unnecessary medical tests and follow-ups.
Area of Science:
- Ophthalmology
- Medical Genetics
- Retinal Imaging
Background:
- Benign yellow dot maculopathy (BYDM) is a rare condition characterized by distinct macular findings.
- Understanding its morphological and functional characteristics is crucial for accurate diagnosis and management.
Purpose of the Study:
- To characterize the clinical presentation of benign yellow dot maculopathy.
- To investigate the potential for familial transmission and long-term progression of BYDM.
Main Methods:
- Comprehensive ocular examinations including best-corrected visual acuity (BCVA) and optical coherence tomography (OCT).
- Advanced imaging techniques such as blue-light fundus autofluorescence (BAF) and near-infrared autofluorescence (NIR-AF).
- Examination of first-degree family members to assess for vertical transmission.
Main Results:
- 25 individuals from 19 families diagnosed with BYDM, with a median age of 37 years.
- All patients maintained BCVA of 20/25 or better; yellow dots were observed in the macula, extending to vascular arcades in many.
- OCT showed minimal abnormalities in some, while autofluorescence revealed specific patterns (hyper-autofluorescent on BAF, hypo-autofluorescent on NIR-AF).
Conclusions:
- BYDM often presents with a mild phenotype, potentially leading to underdiagnosis.
- The condition demonstrates hypo-autofluorescence on NIR-AF and lacks significant morphological or functional progression.
- Early identification of BYDM can reduce unnecessary investigations and patient anxiety.

